Quest DiagnosticsDGXEarnings & Financial Report
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Revenue
$2.8B
Gross Profit
$943.0M
Operating Profit
$438.0M
Net Profit
$282.0M
Gross Margin
34.2%
Operating Margin
15.9%
Net Margin
10.2%
YoY Growth
15.2%
EPS
$2.47
Quest Diagnostics Q2 FY2025 Financial Summary
Quest Diagnostics reported revenue of $2.8B (up 15.2% YoY) for Q2 FY2025, with a net profit of $282.0M (up 23.1% YoY) (10.2% margin). Cost of goods sold was $1.8B, operating expenses totaled $505.0M.
Key Financial Metrics
| Total Revenue | $2.8B |
|---|---|
| Net Profit | $282.0M |
| Gross Margin | 34.2% |
| Operating Margin | 15.9% |
| Report Period | Q2 FY2025 |
Revenue Breakdown
Quest Diagnostics Q2 FY2025 revenue of $2.8B breaks down across 2 segments, led by Diagnostic Information Services Business at $2.7B (97.8% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Diagnostic Information Services Business | $2.7B | 97.8% |
| Other | $62.0M | 2.2% |
Quest Diagnostics Revenue by Segment — Quarterly Trend
Quest Diagnostics revenue by segment across the last 4 reported quarters, showing how each business line (such as Diagnostic Information Services Business and Other) has evolved quarter over quarter.
| Segment | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|
| Diagnostic Information Services Business | — | $2.7B | $2.8B | $2.7B |
| Other | — | $64.0M | $61.0M | $62.0M |
Quest Diagnostics Annual Revenue by Year
Quest Diagnostics annual revenue history includes year-by-year totals (for example, 2025 revenue was $11.0B).
| Year | Annual Revenue |
|---|---|
| 2025 | $11.0B |
| 2024 | $9.9B |
| 2023 | $9.3B |
| 2022 | $9.9B |
Quest Diagnostics Quarterly Revenue & Net Profit History
Quest Diagnostics results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $2.9B | +9.2% | $281.0M | 9.7% |
| Q4 FY2025 | $2.8B | +7.1% | $245.0M | 8.7% |
| Q3 FY2025 | $2.8B | +13.2% | $245.0M | 8.7% |
| Q2 FY2025 | $2.8B | +15.2% | $282.0M | 10.2% |
| Q1 FY2025 | $2.7B | +12.1% | $220.0M | 8.3% |
| Q4 FY2024 | $2.6B | +14.6% | $222.0M | 8.5% |
| Q3 FY2024 | $2.5B | +8.4% | $226.0M | 9.1% |
| Q2 FY2024 | $2.4B | +2.5% | $229.0M | 9.6% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.40B | $2.49B | $2.62B | $2.65B | $2.76B | $2.82B | $2.81B | $2.90B |
| YoY Growth | 2.5% | 8.4% | 14.6% | 12.1% | 15.2% | 13.2% | 7.1% | 9.2% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $13.88B | $16.09B | $16.15B | $15.80B | $15.97B | $16.20B | $16.23B | $16.67B |
| Liabilities | $7.26B | $9.29B | $9.38B | $8.87B | $8.74B | $8.94B | $9.05B | $9.01B |
| Equity | $6.62B | $6.81B | $6.78B | $6.93B | $7.23B | $7.26B | $7.17B | $7.67B |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $360.0M | $356.0M | $464.0M | $314.0M | $544.0M | $563.0M | $465.0M | $278.0M |